Cargando…

Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells

BACKGROUND: Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment failure of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dong-Mei, Zheng, Zi-Hui, Zhang, Ying-Bo, Fan, Shao-Hua, Zhang, Zi-Feng, Wang, Yong-Jian, Zheng, Yuan-Lin, Lu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554918/ https://www.ncbi.nlm.nih.gov/pubmed/31171015 http://dx.doi.org/10.1186/s13046-019-1239-3

Ejemplares similares

Retraction Note: Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
por: Wu, Dong-Mei, et al.
Publicado: (2022)

Strategies of LncRNA DLX6-AS1 on Study and Therapeutics
por: Zhao, Yanyan, et al.
Publicado: (2022)

LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p
por: Hu, Yanping, et al.
Publicado: (2020)

LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
por: Zhao, Zhifeng, et al.
Publicado: (2020)

LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
por: Kuo, Feng-Chih, et al.
Publicado: (2022)

Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1
por: van der Weyden, Louise, et al.
Publicado: (2012)

Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
por: Ding, Xian-zhen, et al.
Publicado: (2021)

Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
Publicado: (2021)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021)

LncRNA AB209371 up-regulated Survivin gene by down-regulating miR-203 in ovarian carcinoma
por: Zheng, Zi-Hui, et al.
Publicado: (2019)

Crosstalk Among YAP, LncRNA, and Tumor-Associated Macrophages in Tumorigenesis Development
por: Xu, Jing, et al.
Publicado: (2022)

LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma
por: Chen, Chiheng, et al.
Publicado: (2021)

Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway
por: Wang, Xuefei, et al.
Publicado: (2019)

Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
por: Chen, Jieqing, et al.
Publicado: (2021)

LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)

lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma
por: Wang, Fan, et al.
Publicado: (2019)

CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
por: Vallath, Sabari, et al.
Publicado: (2016)

lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
por: Liu, Yan, et al.
Publicado: (2020)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms
por: Zhang, Ting‐juan, et al.
Publicado: (2020)

Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression
por: Jiang, Huijuan, et al.
Publicado: (2017)

LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p
por: Kong, Lijun, et al.
Publicado: (2020)

DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis
por: Zhou, Jing-dong, et al.
Publicado: (2022)

lncRNA KCNQ1OT1 Suppresses the Inflammation and Proliferation of Vascular Smooth Muscle Cells through IκBa in Intimal Hyperplasia
por: Ye, Bozhi, et al.
Publicado: (2020)

MicroRNA-155-3p promotes breast cancer progression through down-regulating CADM1
por: Zhang, Guochao, et al.
Publicado: (2019)

LncRNA-ZFAS1 Promotes Myocardial Ischemia-Reperfusion Injury Through DNA Methylation-Mediated Notch1 Down-Regulation in Mice
por: Li, Mengmeng, et al.
Publicado: (2022)

LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma
por: Shi, Fei, et al.
Publicado: (2023)

LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression
por: Mou, Kuanhou, et al.
Publicado: (2019)

Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy
por: Kanke, Yasuyuki, et al.
Publicado: (2019)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
por: Han, Xiaoyang, et al.
Publicado: (2020)

LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis
por: Huang, Shuaihao, et al.
Publicado: (2019)

Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors
por: Wu, Dan, et al.
Publicado: (2021)

LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 Pathways
por: Wang, Jie, et al.
Publicado: (2021)

The lncRNA HNF1A‐AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma
por: Cai, Lijun, et al.
Publicado: (2017)

Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231
por: Liu, Bowei, et al.
Publicado: (2020)

HuR‐regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer
por: Chai, Yiqing, et al.
Publicado: (2016)

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients
por: Leffers, Markus, et al.
Publicado: (2022)

Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
por: Xia, Wenfei, et al.
Publicado: (2020)

U1RNP/lncRNA/Transcription Cycle Axis Promotes Tumorigenesis of Hepatocellular Carcinoma
por: Li, Shun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n0muosc9cg5rrnno16dt7lcs3n